JP2009539822A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539822A5
JP2009539822A5 JP2009513791A JP2009513791A JP2009539822A5 JP 2009539822 A5 JP2009539822 A5 JP 2009539822A5 JP 2009513791 A JP2009513791 A JP 2009513791A JP 2009513791 A JP2009513791 A JP 2009513791A JP 2009539822 A5 JP2009539822 A5 JP 2009539822A5
Authority
JP
Japan
Prior art keywords
carbon atoms
pharmaceutically acceptable
formula
kit according
ome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009513791A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/001528 external-priority patent/WO2007144725A2/en
Publication of JP2009539822A publication Critical patent/JP2009539822A/ja
Publication of JP2009539822A5 publication Critical patent/JP2009539822A5/ja
Pending legal-status Critical Current

Links

JP2009513791A 2006-06-09 2007-06-07 副腎のβ−１１−ヒドロキシラーゼの定量用トレーサーとしての１８Ｆ標識アルキル−１−［（１Ｒ）−１−フェニルエチル］−１Ｈ−イミダゾール−５−カルボキシレートの合成と評価 Pending JP2009539822A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81215906P 2006-06-09 2006-06-09
PCT/IB2007/001528 WO2007144725A2 (en) 2006-06-09 2007-06-07 SYNTHESIS AND EVALUATION OF 18F-LABELLED ALKYL-1-[(R)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE AS A TRACER FOR THE QUANTIFICATION OF β-11-HYDROXYLASE ENZYME IN THE ADRENAL GLANDS

Publications (2)

Publication Number Publication Date
JP2009539822A JP2009539822A (ja) 2009-11-19
JP2009539822A5 true JP2009539822A5 (enExample) 2011-06-16

Family

ID=38658301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009513791A Pending JP2009539822A (ja) 2006-06-09 2007-06-07 副腎のβ−１１−ヒドロキシラーゼの定量用トレーサーとしての１８Ｆ標識アルキル−１−［（１Ｒ）−１−フェニルエチル］−１Ｈ−イミダゾール−５−カルボキシレートの合成と評価

Country Status (4)

Country Link
US (1) US8071785B2 (enExample)
EP (1) EP2035393A2 (enExample)
JP (1) JP2009539822A (enExample)
WO (1) WO2007144725A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2214722A1 (en) * 2007-11-07 2010-08-11 GE Healthcare BV Stabilization of radiopharmaceuticals
RU2540116C2 (ru) 2008-03-31 2015-02-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги этомидата с улучшенными фармакокинетическими и фармакодинамическими свойствами
CN104168899B (zh) * 2012-01-13 2017-04-05 通用医疗公司 麻醉剂化合物及其相关的使用方法
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
JP6048958B2 (ja) 2012-12-27 2016-12-21 日本メジフィジックス株式会社 副腎疾患の画像診断剤
JP2015110563A (ja) * 2013-11-08 2015-06-18 日本メジフィジックス株式会社 アルドステロン合成酵素阻害剤
AU2015281060B2 (en) * 2014-06-26 2019-03-14 Kyoto University 2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicine containing same
US11266753B2 (en) 2017-12-28 2022-03-08 Nihon Medi-Physics Co., Ltd. 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimtdazole derivative compound, and medicament including same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189859B2 (en) * 2003-08-06 2007-03-13 Ilse Zolle Radiolabelled phenylethyl imidazole carboxylic acid ester derivatives

Similar Documents

Publication Publication Date Title
JP2009143956A5 (enExample)
EP2550965A3 (en) Ceramide derivatives for treating polycystic kidney disease
BR0316902A (pt) Processos para preparar (+)duloxetina e hidrocloreto de (+)duloxetina, sal de ácido quiral e (+)duloxetina, di-p-toluil tartarato de (+)duloxetina, (+)duloxetina e composição farmacêutica
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
SE0400235D0 (sv) New composition containing quinoline compounds
JP2012506896A5 (enExample)
CY1111275T1 (el) Κρυσταλλικη μορφη μιας ενωσης κινολινονης-καρβοξαμιδιου
JP2009501198A5 (enExample)
CY1112911T1 (el) Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο
JP2005536503A5 (enExample)
JP2016531126A5 (enExample)
WO2005110982A3 (en) Substituted 1-benzyl-4-substituted piperazine analogues
RU2008127541A (ru) Новые соли
EA022994B1 (ru) Способ подавления толерантности к опиоидному анальгетику
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
DE502006002659D1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3-indolyl)-butylü-1-piperazinyl)-benzofuran-2-carboxamid
RU2007119432A (ru) Способ лечения рака
JP2008546809A5 (enExample)
BRPI0510278A (pt) método para produzir compostos, produto, e, composto
BRPI0817712A2 (pt) Sal de sódio cristalino de ácido 5,6-dimetil-oxo-xantano-4-acético, forma cristalina do mesmo, processos para preparar sal de sódio cristalino de ácido 5,6-dimetil-oxo-xantano-4-acético, e, para preparar forma cristalina, composição farmacêutica, método para preparar uma composição farmacêutica, uso de um sal de sódio cristalino de dmxaa, método para tratar câncer, kit de partes, e, formulação farmacêutica
JP2007519685A5 (enExample)
JP2004525111A5 (enExample)
UY28651A1 (es) Metodos
RU2013106503A (ru) Способ получения контрастных агентов
CA2553231A1 (en) Amine salt of carbostyril derivative